you are here: HomeNewsCovaxin
covaxin
Jump to
156 Results Found
  • Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts May 05, 2021 12:43 PM IST

    Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts

    Companies other than Bharat Biotech must be given contracts to manufacture the indigenously developed Covaxin in bulk. This is the time to open licensing to any company that wants to produce vaccines and for anyone who wants to take a jab, per doctors.

  • Covid vaccine production and availability: What we know so far May 04, 2021 02:23 PM IST

    Covid vaccine production and availability: What we know so far

    So far, 15.5 crore doses have been administered since January and the central and state governments along with the private sector aim to get 30 crore more doses in three months until July.

  • Covaxin effective against Brazil, UK and Indian 'double mutant' COVID-19 strain: ICMR-NIV study May 04, 2021 08:52 AM IST

    Covaxin effective against Brazil, UK and Indian 'double mutant' COVID-19 strain: ICMR-NIV study

    The B.1.617 variant is also being called a 'double mutant' or the 'Indian strain'.

  • Govt Explores Possibility of Producing Covaxin Abroad Amid Supply Crunch: Report May 01, 2021 10:07 AM IST

    Govt Explores Possibility of Producing Covaxin Abroad Amid Supply Crunch: Report

    Covaxin has received Emergency Use Authorisation in several countries across the globe with another 60 in process.

  • COVID-19 Vaccine Tracker: Over 20 lakh jabbed on April 28, 15.21 crore shots administered so far Apr 30, 2021 11:10 AM IST

    COVID-19 Vaccine Tracker: Over 20 lakh jabbed on April 28, 15.21 crore shots administered so far

    The cumulative number of COVID-19 vaccine doses administered in the country stands at 15,21,05,563.

  • Mumbai stops COVID-19 vaccination drive till May 2 due to shortage of jabs Apr 30, 2021 08:16 AM IST

    Mumbai stops COVID-19 vaccination drive till May 2 due to shortage of jabs

    BMC said the vaccination drive for the 18-44 age group, scheduled to begin from May 1 earlier, was likely to be deferred.

  • Bharat Biotech reduces Covaxin price for states to Rs 400 per dose Apr 29, 2021 05:55 PM IST

    Bharat Biotech reduces Covaxin price for states to Rs 400 per dose

    Bharat Biotech had earlier set Covaxin’s price at Rs 600 per dose for state governments. The company decided to reduce the price in view of the enormous challenges the second wave of the pandemic has posed for the public healthcare systems.

  • COVID-19 vaccine: Centre mulls GST waiver to lower prices Apr 29, 2021 12:28 PM IST

    COVID-19 vaccine: Centre mulls GST waiver to lower prices

    The Centre has decided to open up the vaccination drive for everyone above 18 from May 1 onwards.

  • Kerala government to purchase one crore COVID vaccine doses from open market Apr 28, 2021 06:48 PM IST

    Kerala government to purchase one crore COVID vaccine doses from open market

    The state government announced that of the one crore vaccines to be purchased, 70 lakh doses will be Covishield and 30 lakh Covaxin. The said number of doses will be procured between May and July for Rs 483 crore.

  • COVID-19 vaccines | Bharat Biotech's Covaxin found to neutralise '617' coronavirus variant: Dr Anthony Fauci Apr 28, 2021 07:53 AM IST

    COVID-19 vaccines | Bharat Biotech's Covaxin found to neutralise '617' coronavirus variant: Dr Anthony Fauci

    White House chief medical adviser Dr Anthony Fauci said COVID-19 vaccination could be a very important antidote to the pandemic difficulty being seen India.

  • Coronavirus News Highlights: Kerala govt to purchase one crore COVID-19 vaccines Apr 28, 2021 07:34 AM IST

    Coronavirus News Highlights: Kerala govt to purchase one crore COVID-19 vaccines

    Coronavirus News Highlights: Registering a steady increase, the active cases have risen to 29,78,709, comprising 16.55 percent of the total infections

  • Covishield, Covaxin effective against 'Indian strain' of COVID-19, study suggests Apr 27, 2021 10:53 PM IST

    Covishield, Covaxin effective against 'Indian strain' of COVID-19, study suggests

    Anurag Agrawal, the Director of the Institute of Genomics and Integrative Biology (IGIB), said the study on effectiveness of the available vaccines on the B.1.617 variant of SARS-CoV2 suggests that post vaccination, the infections are milder.

  • Lack of transparency in pricing is bad for India’s COVID-19 vaccine drive and economy Apr 27, 2021 03:30 PM IST

    Lack of transparency in pricing is bad for India’s COVID-19 vaccine drive and economy

    If such public money has been used in the development of COVID-19 vaccines, there should be enough transparency in the pricing of these vaccines, too

  • Gujarat to give free COVID-19 vaccines to 18-45 age group from May 1 Apr 25, 2021 10:10 PM IST

    Gujarat to give free COVID-19 vaccines to 18-45 age group from May 1

    The state government will buy one crore doses of Covishield vaccine from Pune's Serum Institute of India and 50 lakh doses of Covaxin from Bharat Biotech in Hyderabad, an official release said.

  • Mumbai gets 1.5 lakh Covishield vaccines, oxygen supply normal: BMC Chief I S Chahal Apr 25, 2021 08:22 PM IST

    Mumbai gets 1.5 lakh Covishield vaccines, oxygen supply normal: BMC Chief I S Chahal

    Chahal said that Covaxin will be available only at select centres for the second dose due to 'extremely limited' existing stock.

  • Bharat Biotech's Covaxin to be sold at Rs 600/dose to states, Rs 1,200 to private hospitals Apr 24, 2021 10:15 PM IST

    Bharat Biotech's Covaxin to be sold at Rs 600/dose to states, Rs 1,200 to private hospitals

    Bharat Biotech further announced that it will also export Covaxin and the export price of the vaccine would be between $15-$20, i.e., between Rs 1,100 to Rs 1,500 per dose, approximately.

  • Explained | How the new vaccination drive is expected to roll out Apr 23, 2021 11:16 AM IST

    Explained | How the new vaccination drive is expected to roll out

    On April 19, the central government announced a major shift in its Covid-19 vaccination strategy. Moneycontrol takes a look at what these changes mean.

  • Take a jab! 12 healthcare stocks hit fresh 52-week high; huge opportunity for long term investors? Apr 22, 2021 10:14 AM IST

    Take a jab! 12 healthcare stocks hit fresh 52-week high; huge opportunity for long term investors?

    The year that started out on a sizzling note has fizzled out, with only the pharma sector - naturally - emerging as the top performer, quite like 2020

  • COVID-19 update | Covishield comprises over 90% of 12.76 crore vaccines administered so far Apr 21, 2021 05:08 PM IST

    COVID-19 update | Covishield comprises over 90% of 12.76 crore vaccines administered so far

    Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India.

  • Bharat Biotech Covaxin demonstrates 78% efficacy in Phase-3 interim analysis Apr 21, 2021 03:19 PM IST

    Bharat Biotech Covaxin demonstrates 78% efficacy in Phase-3 interim analysis

    Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a point estimate of vaccine efficacy of 78 percent against mild, moderate, and severe COVID-19 disease, the company said.

  • COVID-19 vaccines to cost Rs 1,000 in private market, Bharat Biotech wants 'maximum' price for Covaxin Apr 21, 2021 12:22 PM IST

    COVID-19 vaccines to cost Rs 1,000 in private market, Bharat Biotech wants 'maximum' price for Covaxin

    Bharat Biotch expects to reach a production capacity of up to 800 million doses per annum by July-August.

  • COVID vaccine shortage | What if you miss second dose, will mix and match work, and other questions answered Apr 20, 2021 05:45 PM IST

    COVID vaccine shortage | What if you miss second dose, will mix and match work, and other questions answered

    Many who received the first dose in the first week of March when the vaccination drive started are supposed to take the second dose this week or in the next few days.

  • COVID-19 update | Bharat Biotech announces COVAXIN capacity expansion to support vaccination campaigns in India, worldwide Apr 20, 2021 03:10 PM IST

    COVID-19 update | Bharat Biotech announces COVAXIN capacity expansion to support vaccination campaigns in India, worldwide

    The capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore, to reach over 700 million doses per year, which are one of the largest production capacities for inactivated viral vaccines worldwide.

  • Deregulation of vaccine rollout: What it means for pharma players Apr 20, 2021 10:11 AM IST

    Deregulation of vaccine rollout: What it means for pharma players

    Dr Reddy’s, Gland Pharma, Strides, Cadila, Aurobindo are some of the names that merit a close watch as operating leverage plays out

  • Govt gives ‘advance’ of around Rs 4,500 crore to Serum Institute of India, Bharat Biotech Apr 19, 2021 09:19 PM IST

    Govt gives ‘advance’ of around Rs 4,500 crore to Serum Institute of India, Bharat Biotech

    “The Finance Ministry today has relaxed the general financial rules and permitted the Ministry of Health to pay, if they so wish, to make advance payment to vaccine suppliers, without a bank guarantee. I believe the Health Ministry is already doing so,” a top official told Moneycontrol

Sections